Across TCGA pan-cancer cohorts, MORF4L2-AS1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated MORF4L2-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MORF4L2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MORF4L2-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCS show a favorable association.

BLCA, UCS, and READ are the cancer types where MORF4L2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	III,IV	0.762	0.595	.001	76	view →
UCS	DFS	Median	IV	0.952	0.367	.001	56	view →
READ	OS	Median	III,IV	0.661	0.285	.002	40	view →
PAAD	DFS	Tertile	All	0.591	0.263	.002	33	view →
KIRP	DFS	Median	All	0.505	0.697	.001	33	view →
COAD	DFS	Tertile	All	0.703	0.867	.002	29	view →
ESCA	DFS	Median	All	0.219	0.434	.002	23	view →
UVM	DFS	Quartile	III,IV	0.266	0.830	.014	20	view →
UCEC	DFS	Tertile	All	0.415	0.725	.013	20	view →
PRAD	DFS	Tertile	All	0.828	0.926	.005	18	view →
SKCM	OS	Tertile	IV	0.745	0.301	.011	16	view →
LUSC	DFS	Quartile	III,IV	0.492	0.744	.016	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

Exploration

Same gene, other analysis: MORF4L2-AS1 tumor-vs-normal RNA expression · all MORF4L2-AS1 data types